Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia

Blood

Volumn 89, Issue 9, 1997, Pages 3113-3117

  Keil, Felix ^a   Haas, Oskar A ^b   Fritsch, Gerhard ^b   Kalhs, Peter ^b   Lechner, Klaus ^b   Mannhalter, Christine ^b   Reiter, Elisabeth ^b   Niederwieser, Dietger ^b   Hoecker, Paul ^b   Greinix, Hildegard T ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; APLASIA; ARTICLE; BONE MARROW TRANSPLANTATION; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT SURVIVAL; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL;

EID: 0030916862     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3113     Document Type: Article

References (17)

1. Mrsic M, Horowitz M, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Gajewski JL, Gale RP Herzig RH, Prentice HG, Rozman C, Sobocinski KA, Speck B, Bortin MM: Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 9:268, 1992
2. Giralt S, Champlin E: Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 84:3603, 1994
3. Arcese W, Mauro FR, Alimena G, LoCoco F, DeCuia MR, Screni M, Iori AP, Montefusco E, Mandelli F: Interferon therapy for Ph 1 positive CML patients relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 5:309, 1990
4. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacob-sen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, Rhee F, Mittermüller J, Witte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 86:2041, 1995
5. Porter D, Roth MS, McGarigle C, Ferrara JL, Antin JH: Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 330:100, 1994
6. Hertenstein B, Wiesneth M, Novotny J, Bunjes D, Stefanic M, Heinze B, Hiibner G, Heimpel H, Arnold R: Interferon-α and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation 56:1114, 1993
7. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyctosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
8. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Engl J Med 292:832, 895, 1975
9. Mitterbauer G, Födinger M, Scherrer R, Knöbl P, Jäger U, Laezika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H, Kalhs P, Linkesch W, Lechner K, Mannhalter Ch: PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. Br J Haematol 89:937, 1995
10. Gaiger A, Mannhalter C, Hinterberger W, Haas O, Marosi C, Kier P, Eichinger S, Funovich M, Lechner K: Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Ann Hematol 63:227, 1991
11. + myeloid progenitors using CD45-RA analysis. Blood 81:2301, 1993
12. Couthinho LH, Will A, Radford J, Schiro R, Testa N, Dexter M: Effects of human granulocyte-colony stimulating factor (CSF), human granulocyte-macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Blood 75:2118, 1990
13. Keil F, Kalhs P, Haas OA, Fritsch G, Mitterbauer G, Brugger S, Lechner K, Schwarzinger I, Mannhalter Ch, Linkesch W, Kurz M, Greinix HT: Graft failure after donor leukocyte infusion in relapsed chronic myeloid leukemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion. Br J Haematol 94:120, 1996
14. Verfaillie CM, Miller WJ, Boylan K: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
15. Faber LM, van derHoeven J, Goulmy E, Hooftman-den Otter L, Van Luxenburg-Heijs S, Willemze R, Falkenburg F: Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen specific cytotoxic T lymphocytes. J Clin Invest 96:877, 1995
16. Marijt W, Veenhof WFJ, Goulmy E, Willemze R, van Rood JJ, Falkenburg JHF: Minor histocompatibility antigens HA 1, 2 and 4 and HY specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell contact. Blood 82:3778, 1993
17. Van Rhee F, Lin F, Cullis Jo, Spencer A, Cross NC, Chase A, Garicochea B, Bungey J, Barett J, Goldman JM: Relapse of chromic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83:3377, 1994